Kenya has been granted a license to manufacture a new monthly HIV-prevention pill for the African market, a significant milestone in making vital medicine more accessible on the continent.

• Kenya is one of three African countries licensed to produce the drug as part of the HIV medicine project from its inception.
• Pharmaceutical firm Merck will license seven generic drug makers, including those in Kenya, to produce a low-cost version of the pill.
• This initiative aims to address the "triple threat" of new HIV infections, teenage pregnancies, and sexual and gender-based violence, despite a significant drop in new HIV infections by 82% over the last decade.